CIBC Private Wealth Group’s Supernus Pharmaceuticals SUPN Stock Holding History

CIBC Private Wealth Group’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$646	Buy	+13	New	+$632	﹤0.01%	2996
2025 Q2	–	Sell	-12	Closed	-$368	–	3304
2025 Q1	$368	Buy	+12	New	+$425	﹤0.01%	2920
2022 Q4	–	Sell	-14,531	Closed	-$492K	–	935
2022 Q3	$492K	Buy	+14,531	New	+$473K	﹤0.01%	706
2018 Q3	–	Sell	-33,242	Closed	-$1.99M	–	1633
2018 Q2	$1.99M	Buy	33,242 +33,034	+15,882%	+$1.71M	0.01%	496
2018 Q1	$10K	Sell	208 -43	-17%	-$1.79K	﹤0.01%	1536
2017 Q4	$10K	Buy	+251	New	+$9.92K	﹤0.01%	1555

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's SUPN Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Supernus Pharmaceuticals (SUPN) in Q4 2025: 13 shares worth $646. The stake represents ﹤0.01% of the portfolio and ranks #2996 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in SUPN as recently as Q1 2025.

CIBC Private Wealth Group first reported a position in SUPN in Q4 2017 and has held it in 6 quarters since. The position peaked at $1.99M in Q2 2018. 333 funds tracked by Wall St. Rank hold SUPN as of Q4 2025.

CIBC Private Wealth Group held 13 shares of Supernus Pharmaceuticals worth $646 as of Q4 2025.
Supernus Pharmaceuticals was a new CIBC Private Wealth Group position in Q4 2025.
Supernus Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2996 holding.
CIBC Private Wealth Group first reported a position in Supernus Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
CIBC Private Wealth Group's Supernus Pharmaceuticals position peaked at $1.99M in Q2 2018.
333 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.